Can You Stay on 1.7mg Wegovy Without Moving Up?

The myth worth clearing up first: 1.7mg is not a "nearly there" dose

A lot of people assume the Wegovy schedule works like a ladder you must climb to the top rung before treatment is taken seriously. It does not. The titration sequence (0.25mg, 0.5mg, 1.0mg, 1.7mg, 2.4mg) exists to help your body adjust gradually and reduce the nausea and gastrointestinal discomfort that can come with starting a GLP-1 medicine. Each step is a real dose of semaglutide, not a preparatory one.

The 1.7mg dose produces meaningful appetite suppression and slows gastric emptying in the same way the higher dose does, just at a lower intensity. If weight loss is progressing steadily and you are tolerating treatment comfortably, your prescriber may see no clinical reason to push further. The full breakdown of Wegovy's dose steps explains what changes at each level, but the key point here is that 1.7mg is not a consolation prize.

Letting go of the idea that 2.4mg is the only "real" dose is, genuinely, one of the most useful things people can do early in treatment. It stops people feeling like they are behind when they are not.

What your prescriber weighs up when deciding whether to stay at 1.7mg

Under the Wegovy SmPC and NICE's guidance, the titration schedule moves upward roughly every four weeks, but only when clinically appropriate. Your prescriber is not obliged to push you to the next dose if there is a good reason to stay where you are. The factors that typically come into that conversation include: how much weight you have lost since starting or reaching 1.7mg; whether side effects are still present or have settled; and whether there are any reasons (medical or practical) that make a higher dose less suitable right now.

If you have been at 1.7mg for a sustained period and are still losing weight at a pace that reflects genuine progress, the case for stepping up is weaker than it would be if things had stalled. Conversely, if progress has plateaued and side effects are manageable, your prescriber might suggest trying 2.4mg to see whether the additional dose shifts things. Either way, the question of how long you stay on any Wegovy dose is one that deserves a proper clinical conversation, not a unilateral decision.

The cost picture for Wegovy in the UK is worth understanding separately, particularly because private prescriptions are renewed on a per-dose basis and pricing can vary by step.

When side effects are the reason you are staying at 1.7mg

Gastrointestinal side effects (nausea, loose stools, reflux, sluggish digestion) are the most common reason people find a particular dose harder to move past. The NHS medicines page for semaglutide lists these as known and common effects, particularly after dose changes, and notes they often settle within a few weeks.

If you are at 1.7mg and still experiencing these effects regularly, your prescriber might recommend staying at this level for longer than the standard four-week window before reconsidering a step up. That is a sensible, evidence-consistent approach, not a failure of treatment. Pushing to 2.4mg while you are still symptomatic is likely to make side effects worse, not better, and may lead to a dose reduction anyway. Staying at 1.7mg temporarily while you adjust is usually the more pragmatic path.

There is also a separate question about tolerability at lower doses for people who have found earlier steps genuinely difficult, for context, staying on a lower Wegovy dose long-term is an option some prescribers and patients agree on together, particularly when any step up reliably causes significant distress.

The role of exercise and lifestyle alongside dose decisions

Weight-loss medicines are licensed as an adjunct to a reduced-calorie diet and increased physical activity, and that framing matters when you are thinking about dose. If 1.7mg is giving you the appetite suppression you need to make sustainable changes to how you eat and move, the case for staying at this dose strengthens considerably. The number on the pen matters less than the overall clinical picture.

Some people find that adding structured movement (particularly resistance work) changes what a given dose achieves for them. Strength training alongside Wegovy is worth exploring with your prescriber if you are wondering how to make the most of your current dose before discussing a step up.

Wegovy is a weight management treatment designed to work alongside lifestyle change, not instead of it. A prescriber who reviews your progress as a whole (not just the dose number) is best placed to advise you. If you would like a clinical review of where you are in treatment and whether 1.7mg is the right place to stay, start a free consultation with our prescribers today.